Respiratory Medicine: A Comprehensive Update on Interstitial Lung Disease and Legionella and Leptospirosis.
On-demand recorded 24 Jun 2024
This webinar provides an enlightening journey through the intricate world of Interstitial Lung Diseases (ILD) as we unravel the spectrum of conditions and unveil indicators of poor prognosis. Gain invaluable insights into the latest advancements in anti-fibrotic medications, empowering you to navigate treatment options with confidence.
Explore the nuances of terminology as we debunk the myth of 'atypical pneumonia', understanding why precision in language matters. Delve into the clinical landscape of pneumonia, unraveling the mysteries of classically 'atypical' organisms such as Legionella species and Leptospira. Enhance your diagnostic prowess and refine your management strategies, ensuring optimal patient care.
Don't miss this opportunity to expand your knowledge and elevate your practice in respiratory medicine.
Learning outcomes
- Outline the broad spectrum of ILD and features which indicate a likely poor outcome.
- Demonstrate familiarity with the current anti-fibrotic medications.
- Identify what is meant by ‘atypical pneumonia’ and why this is not a preferred term.
- Summarise common clinical features and management of classically ‘atypical’ organisms causing pneumonia, particularly legionella species and leptospira.
Facilitator
Dr Tim Senior
MBBS, FRACGP
Dr Tim Senior is a GP at the Tharawal Aboriginal Corporation in South West Sydney. He is Medical Advisor to the RACGP in Aboriginal and Torres Strait Islander Health and is a clinical senior lecturer in general practice and Indigenous Health at the University of Western Sydney.
Presenters
Dr Lewis Holmes
Respiratory and Sleep Physician
Dr Lewis Holmes is a Respiratory and Sleep Physician working at Macquarie University Hospital. He completed his training at Concord, Liverpool, and Dubbo Hospitals. He is an investigator on several clinical trials running at Macquarie University Hospital.
Dr Elizabeth Veitch
Respiratory and Sleep Medicine Physician
Dr Elizabeth Veitch is a Respiratory and Sleep Medicine Physician at Concord General Hospital, and practises privately in Wahroonga. Her area of sub-specialty interest is in Interstitial Lung Diseases (ILD). Since 2009 she has been a principal investigator on 20 international, multi-centre trials of novel medications for Idiopathic Pulmonary Fibrosis, Scleroderma-ILD and Progressive Fibrosing ILD. Several of these trials yielded positive results which have dramatically changed the management, and improved the prognosis, of these devastating diseases. She chairs the ILD Multi-disciplinary meetings at both Concord Hospital and Macquarie University Hospital.